Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques

Human T cell leukemia/T-lymphotropic virus type 1 (HTLV-1) infection occurs by cell-to-cell transmission and can induce fatal adult T cell leukemia. Vaccine development is critical for the control of HTLV-1 transmission. However, determining whether vaccine-induced anti-Env antibodies can prevent ce...

Full description

Saved in:
Bibliographic Details
Published inMolecular therapy Vol. 32; no. 7; pp. 2328 - 2339
Main Authors Nakamura-Hoshi, Midori, Ishii, Hiroshi, Nomura, Takushi, Nishizawa, Masako, Hau, Trang Thi Thu, Kuse, Nozomi, Okazaki, Midori, Ainai, Akira, Suzuki, Tadaki, Hasegawa, Hideki, Yoshida, Takeshi, Yonemitsu, Kenzo, Suzaki, Yuriko, Ami, Yasushi, Yamamoto, Hiroyuki, Matano, Tetsuro
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 03.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Human T cell leukemia/T-lymphotropic virus type 1 (HTLV-1) infection occurs by cell-to-cell transmission and can induce fatal adult T cell leukemia. Vaccine development is critical for the control of HTLV-1 transmission. However, determining whether vaccine-induced anti-Env antibodies can prevent cell-to-cell HTLV-1 transmission is challenging. Here, we examined the protective efficacy of a vaccine inducing anti-Env antibodies against HTLV-1 challenge in cynomolgus macaques. Eight of 10 vaccinated macaques produced anti-HTLV-1 neutralizing antibodies (NAbs) and were protected from an intravenous challenge with 108 HTLV-1-producing cells. In contrast, the 2 vaccinated macaques without NAb induction and 10 unvaccinated controls showed HTLV-1 infection with detectable proviral load after challenge. Five of the eight protected macaques were administered with an anti-CD8 monoclonal antibody, but proviruses remained undetectable and no increase in anti-HTLV-1 antibodies was observed even after CD8+ cell depletion in three of them. Analysis of Env-specific T cell responses did not suggest involvement of vaccine-induced Env-specific T cell responses in the protection. These results indicate that anti-Env antibody induction by vaccination can result in functionally sterile HTLV-1 protection, implying the rationale for strategies aimed at anti-Env antibody induction in prophylactic HTLV-1 vaccine development. [Display omitted] Matano and colleagues indicate that anti-Env antibody induction by vaccination can result in functionally sterile HTLV-1 protection. Results highlight the rationale for strategies aimed at anti-Env antibody induction in prophylactic HTLV-1 vaccine development.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1525-0016
1525-0024
1525-0024
DOI:10.1016/j.ymthe.2024.05.020